Pacifica Partners Inc. Aurinia Pharmaceuticals Inc. Transaction History

Pacifica Partners Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	BUY	$8.95 - $12.8 $8,950 - $12,800	1,000 New	1,000 $10,000
Q4 2021 Jan 13, 2022	SELL	$17.78 - $33.08 $5,334 - $9,924	-300 Closed	0 $0
Q3 2021 Oct 07, 2021	SELL	$10.93 - $23.55 $39,894 - $85,957	-3,650 Reduced 92.41%	300 $7,000
Q2 2021 Jul 14, 2021	BUY	$10.0 - $14.52 $3,000 - $4,356	300 Added 8.22%	3,950 $50,000
Q1 2021 Apr 08, 2021	BUY	$12.3 - $18.73 $12,300 - $18,730	1,000 Added 37.74%	3,650 $47,000
Q1 2020 Apr 15, 2020	BUY	$11.34 - $21.46 $7,087 - $13,412	625 Added 30.86%	2,650 $38,000
Q4 2019 Feb 04, 2020	BUY	$3.88 - $21.42 $7,857 - $43,375	2,025 New	2,025 $41,000

191

56.2M

499K

637K

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.03B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Pacifica Partners Inc., based on Form 13F filings with the SEC.

Stay updated on Pacifica Partners Inc. with notifications on news.